Cencora Inc. (COR)vsHenry Schein Inc (HSIC)
COR
Cencora Inc.
$326.91
-1.46%
HEALTHCARE · Cap: $65.11B
HSIC
Henry Schein Inc
$72.29
-0.54%
HEALTHCARE · Cap: $8.51B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 2371% more annual revenue ($325.78B vs $13.18B). COR leads profitability with a 50.0% profit margin vs 3.0%. COR appears more attractively valued with a PEG of 0.82. COR earns a higher WallStSmart Score of 62/100 (C+).
COR
Buy62
out of 100
Grade: C+
HSIC
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-44.0%
Fair Value
$253.90
Current Price
$326.91
$73.01 premium
Margin of Safety
+12.5%
Fair Value
$93.39
Current Price
$72.29
$21.10 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 134 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 118.0%
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
Trading at 33.3x book value
Negative free cash flow — burning cash
Expensive relative to growth rate
3.0% margin — thin
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 50.0% and operating margin at 118.0%. PEG of 0.82 suggests the stock is reasonably priced for its growth.
Bull Case : HSIC
The strongest argument for HSIC centers on Price/Book.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Price/Book, Free Cash Flow. A P/E of 40.2x leaves little room for execution misses.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
COR profiles as a mature stock while HSIC is a value play — different risk/reward profiles.
HSIC carries more volatility with a beta of 0.85 — expect wider price swings.
HSIC is growing revenue faster at 7.7% — sustainability is the question.
HSIC generates stronger free cash flow (338M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 56/100), backed by strong 50.0% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?